0521779407-10 CUNY1086/Karliner 0 521 77940 7 June 7, 2007 18:40
844 Interstitial Lung Diseases
■Baseline PFTs, CXR, CT
■Treat intercurrent infection
■Avoid aspiration; asymptomatic acid reflux common
specific therapy
Indications
■Presence of disease unless extremely end-stage
Treatment Options
■Antiinflammatory therapy:
➣prednisone
➣azathioprine, cyclophosphamide: usually added as second agent
to spare steroid adverse effects
➣Colchicine: may be antifibrotic; efficacy unclear
■Referral for lung transplantation
Side Effects & Contraindications
■Prednisone:
➣Systemic effects of steroids
➣If used with azathioprine or cyclophosphamide, give PCP pro-
phylaxis
➣Contraindications:
Absolute: prior severe adverse reactions
Relative: mild diabetes, past history of ulcers, anxiety and irri-
tability
■Azathioprine:
➣Side Effects: bone marrow suppression, liver toxicity, nausea,
future malignancy
➣Contraindications
Absolute: liver disease, low blood counts
Relative: mildly low blood counts
■Cyclophosphamide:
➣Side effects: bone marrow suppression, esp leukopenia (adjust
dose), bladder hemorrhage (take with large volume of water early
in day), bladder tumors, azoospermia and amenorrhea, nausea,
future malignancy
➣Contraindications
Absolute: preexisting hematologic abnormalities
Relative: mild hematologic abnormalities
■Colchicine:
➣Side effects: diarrhea, muscle weakness
➣Contraindications: